- Filed
- Nov 13, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2020 · Oct 30, 2020 | 114.23M sh |
| Cash And Equivalents | Q3 2020 · Sep 30, 2020 | $125.74M |
| Cash And Equivalents | Q3 2020 · Dec 31, 2019 | $168.98M |
| Shares Diluted | Q3 2020 · Aug 31, 2020 | 113.89M sh |
| Shares Diluted | Q3 2020 · Aug 31, 2020 | 118M sh |
| Shares Diluted | Q3 2020 · Sep 30, 2019 | 112.99M sh |
| Shares Diluted | Q3 2020 · Sep 30, 2019 | 119.97M sh |
| Stock Repurchased | Q3 2020 · Aug 31, 2020 | $39.37M |
| Stock Repurchased | Q3 2020 · Sep 30, 2019 | $75.89M |
| Capex | Q3 2020 · Aug 31, 2020 | $221K |
| Capex | Q3 2020 · Sep 30, 2019 | $504K |
| Stockholders Equity | Q3 2020 · Aug 31, 2020 | $425.21M |
| Stockholders Equity | Q3 2020 · Dec 31, 2019 | $593.2M |
| Stockholders Equity | Q3 2020 · Mar 31, 2019 | $693.78M |
| Stockholders Equity | Q3 2020 · Dec 31, 2018 | $729.78M |
| Eps Diluted | Q3 2020 · Aug 31, 2020 | $0.04 |
| Eps Diluted | Q3 2020 · Aug 31, 2020 | −$0.66 |
| Eps Diluted | Q3 2020 · Sep 30, 2019 | −$0.16 |
| Eps Diluted | Q3 2020 · Sep 30, 2019 | −$0.13 |
| Eps Basic | Q3 2020 · Aug 31, 2020 | $0.04 |
| Eps Basic | Q3 2020 · Aug 31, 2020 | −$0.66 |
| Eps Basic | Q3 2020 · Sep 30, 2019 | −$0.16 |
| Eps Basic | Q3 2020 · Sep 30, 2019 | −$0.13 |
| Sga Expense | Q3 2020 · Aug 31, 2020 | $7.22M |
| Sga Expense | Q3 2020 · Aug 31, 2020 | $29.7M |
| Sga Expense restated | Q3 2020 · Sep 30, 2019 | $10.06M |
| Sga Expense restated | Q3 2020 · Sep 30, 2019 | $27.07M |
| Rd Expense | Q3 2020 · Aug 31, 2020 | $1.05M |
| Rd Expense | Q3 2020 · Aug 31, 2020 | $4.37M |
| Rd Expense | Q3 2020 · Sep 30, 2019 | $4.31M |
| Rd Expense restated | Q3 2020 · Sep 30, 2019 | $6.11M |
| Net Income | Q3 2020 · Aug 31, 2020 | $4.4M |
| Net Income | Q3 2020 · Aug 31, 2020 | −$77.3M |
| Net Income | Q3 2020 · Sep 30, 2019 | −$17.78M |
| Net Income | Q3 2020 · Sep 30, 2019 | −$15.52M |
| Operating Income | Q3 2020 · Aug 31, 2020 | −$8.73M |
| Operating Income | Q3 2020 · Aug 31, 2020 | −$54.25M |
| Operating Income restated | Q3 2020 · Sep 30, 2019 | −$12.97M |
| Operating Income restated | Q3 2020 · Sep 30, 2019 | −$30.45M |
| Cost Of Revenue | Q3 2020 · Aug 31, 2020 | $1.13M |
| Cost Of Revenue | Q3 2020 · Aug 31, 2020 | $6.63M |
| Cost Of Revenue restated | Q3 2020 · Sep 30, 2019 | $4.77M |
| Cost Of Revenue restated | Q3 2020 · Sep 30, 2019 | $13.49M |
| Stock Issued | Q3 2020 · Mar 31, 2020 | 13.4M sh |
| Current Liabilities | Q3 2020 · Dec 31, 2019 | $45.69M |
| Total Liabilities | Q3 2020 · Dec 31, 2019 | $123.93M |
| Current Assets | Q3 2020 · Dec 31, 2019 | $313.9M |
| Total Assets | Q3 2020 · Dec 31, 2019 | $717.21M |